Informações:
Falhas:
ID
34385
Descrição
Longitudinal (Weekly) Follow-up of Active Plaques in Multiple Sclerosis With 3 Teslas Multi-modality MRI Using Diffusion, Perfusion, Venography and Proton Spectroscopy; ODM derived from: https://clinicaltrials.gov/show/NCT00861172
Link
https://clinicaltrials.gov/show/NCT00861172
Palavras-chave
Versões (1)
- 17/01/2019 17/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
17 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Lesions NCT00861172
Eligibility Lesions NCT00861172
- StudyEvent: Eligibility
Similar models
Eligibility Lesions NCT00861172
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
age between 18 and 50 years.
boolean
ID.2
Item
health coverage.
boolean
ID.3
Item
any form of ms defined by mc donald's criteria (2005).
boolean
ID.4
Item
patients having shown an enhanced plaque on a less than six month mri examination.
boolean
ID.5
Item
patients with an immunomodulating therapy like natalizumab (tysabri) and intravenous immunosuppressive therapies. other therapies will not be excluded from this study. for patients treated by systemic corticotherapy, a one-month delay will be necessary before a mri examination.
boolean
ID.6
Item
cerebral microangiopathy (diabetes, arterial hypertension, vascularitis…)
boolean
ID.7
Item
patient with classical mri contraindication like pace-maker, cardiac valvulosis, claustrophobia, allergy to contrast agent …
boolean
ID.8
Item
pregnancy or pregnancy desire.
boolean
ID.9
Item
patient with a low creatinine clearance <60 ml/mn
boolean